This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

US Coagulation Testing Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies

NEW YORK, Aug. 19, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

US Coagulation Testing Market 2013 - Sales Forecasts, Supplier Shares, Competitive Strategies

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years.

The report explores business and technological trends in the US coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance,Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X ( Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Sales and Market Share Analysis- Sales and market shares of major instrument and reagent suppliers. Competitive Assessments- Extensive strategic profiles of major suppliers and emerging market entrants. Market Segmentation Analysis- Comprehensive marketsegmentation analysis, including:

- Hospitals- Commercial/Private Laboratories- Physician Offices- Test volume forecasts for over 40 major procedures by market segment. Current and Emerging Products- Review of established and emerging procedures.- Comparison of automated and semi-automatedanalyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review- Analysis of current and emerging technologies and their potential market applications.- Comprehensive lists of companies developing or marketing new technologies and products by test. Strategic Recommendations- Product development and business expansion opportunities with significant market appeal.- "Ideal" product models with tentativeprices and operating characteristics.- Alternative market penetration strategies for instrument and reagent suppliers.- Potential market entry barriers and risks.

I. IntroductionII. Worldwide Market and Technology OverviewA. Major Routine and Special Coagulation Tests1. Introduction2. Activated Partial Thromboplastin Time (APTT)3. Alpha-2 Antiplasmin4. Antithrombin III5. Bleeding Time6. D-Dimer7. Ethanol Flocculation Test8. Euglobulin Lysis9. Factor Assaysa. Introductionb. Factor IIc. Factor V/Factor V Leidend. Factor VIIe. Factor VIIIf. Factor IXg. Factor IXah. Factor X ( Stuart Factor)i. Factor Xaj. Factor XIk. Factor XIIl. Factor XIII10. Fibrin Degradation Products11. Fibrinogen12. Heparin13. Hirudin

14. Hypercoagulability and Thrombosis15. Lipoprotein a16. Plasmin17. Plasminogen18. Plasminogen Activator Inhibitor (PAI)19. Platelet Function Tests20. Platelet Aggregation21. Proteins C and S22. Prothrombin Fragment 1.223. Prothrombin Time (PT) 24. Reptilase Time25. Thrombin Time26. Tissue-Type Plasminogen Activator (t-PA)27. Von Willebrand's FactorB. Instrumentation ReviewC. Major in Vitro Diagnostic Technologies and TheirPotential Applications1. Chromogenic Substrates2. Monoclonal and Polyclonal Antibodies3. Immunoassays4. Molecular Diagnostics5. Microcomputers6. Automation7. Robotics8. Artificial Intelligence9. Dry Chemistry10. Biosensors

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.34 -0.71%
FB $98.14 -1.60%
GOOG $672.75 -1.50%
TSLA $147.02 -0.66%
YHOO $26.60 -1.70%


Chart of I:DJI
DOW 15,926.51 -100.54 -0.63%
S&P 500 1,841.72 -11.72 -0.63%
NASDAQ 4,250.7660 -32.9870 -0.77%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs